Risk-sharing agreement based on health outcomes for the treatment of moderate-severe psoriasis with certolizumab pegol.

Navarro Ruiz, Andrés; Toledo Alberola, Fernando; Aceituno, Susana

Risk-sharing agreement based on health outcomes for the treatment of moderate-severe psoriasis with certolizumab pegol. / Acuerdo de riesgo compartido basado en resultados de salud para el tratamiento de psoriasis moderada-grave con certolizumab pegol.

Navarro Ruiz, Andrés; Toledo Alberola, Fernando; Aceituno, Susana.

Affiliation

Navarro Ruiz A; Servicio de Farmacia, Hospital General Universitario de Elche, Alicante, España. Electronic address: navarro_and@gva.es.
Toledo Alberola F; Servicio de Dermatología, Hospital General Universitario de Elche, Alicante, España.
Aceituno S; Departamento de Investigación, Outcomes'10, SLU, Castellón, España.

Farm Hosp ; 48(2): 51-56, 2024.

Article in En, Es | MEDLINE | ID: mdl-37739901

Subject(s)

Biological Products; Psoriasis; Adult; Female; Humans; Male; Certolizumab Pegol/therapeutic use; Treatment Outcome; Psoriasis/drug therapy; Psoriasis/chemically induced; Biological Products/therapeutic use; Severity of Illness Index; Quality of Life

Key words

Acuerdos de riesgo compartido; Certolizumab pegol; Efectividad; Effectiveness; Health outcomes; Psoriasis; Resultados en salud; Risk-sharing agreement

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Psoriasis / Biological Products Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En / Es Year: 2024 Type: Article

Fulltext

XML

PubMed Links

Search on Google